Skip to the main content.
TALK TO AN EXPERT Submit Your RFP
TALK TO AN EXPERT Submit Your RFP
Facebook Instagram Linkedin X YouTube Medium
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Where data becomes direction

Clinical development expertise that maximizes every investment and enables confident decisions faster.

TALK TO AN EXPERT →
SPECIALTY CRO SERVICES

Solutions for better decisions across clinical development
 
instat_tab_

Biostatistics & Data powered by InStat™

 

Veristat BSP delivery turns clinical data into decision-ready evidence through biostatistics, statistical programming, data management, standards and InStat-enabled TLF automation.

 

Biostatistics

Statistical Programming

Data Management

InStat

Adaptive Designs

Strategic Consulting/Advisory

Data Monitoring Commitees

Standards Implementation 

Learn More →

complex clinical delivery_

Clinical Operations

Veristat delivers complex Phase I-III clinical trials where patient populations, endpoints, sites, timelines and evidence requirements demand more than capacity.

Project Management

Clinical Site Monitoring and Site Management

Medical Affairs and Pharmacovigilance

Decentralized Clinical Trials

Clinical Trial Rescue Programs

Natural History Studies

Rare Disease Trial Delivery

Participant Recruitment and Retention

Learn More →

regulatory

Regulatory & Submission Readiness

Veristat connects regulatory strategy, medical writing, regulatory writing, editing and publishing so the evidence story holds together before submission pressure hits.

Regulatory Writing

Submission Leadership

Patient Narratives

 

Learn More →

Regulatory and Submissions Readiness

Regulatory & Submissions Readiness

Veristat connects regulatory strategy, medical writing, regulatory writing, editing and publishing so the evidence story holds together before submission pressure hits.

Regulatory Writing

Medical Writing

Strategic Resourcing

Medical Publications

Statistics for Regulatory Submissions (ISS/ISE)

Submission Leadership

Clinical Disclosure & Transparency

Regulatory Operations

Document Quality and Management

 

Learn More →

development and advisory

Development & Advisory

 

Veristat partners with sponsors to shape study design, endpoints, development strategy and regulatory path before capital, timelines and patient trust are put at risk.

Regulatory Consulting

Marketing Applications

Regulatory Publishing

Clinical Trial Safety

Medical devices

 

Learn More →

THERAPEUTIC EXPERTISE

Therapeutic Areas We Specialize In

IN THE NEWS

Veristat Helps Impact Therapeutics Receive CHMP Marketing Authorization for Sepalna

On September 18, 2026, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the...

Read more →

 
NEWSIMAGE

FEATURED

Veristat Expands Biostatistics Leadership to Accelerate AI-Powered Drug Development in Complex Disease Areas

Veristat™, a global clinical research organization (CRO) and consultancy specializing in complex studies, today announced...

Read more →
VERISTAT'S PROVEN IMPACT

Supporting Development Through Regulatory Approval

These numbers reflect programs we've supported from strategy through submission.

 

150+

Statistical analysis plans authored by InStat

30+

Regulatory approvals supported for rare-disease therapies in the past five years

~400

25% of Veristat’s work supports rare disease therapies, including nearly 400 clinical trials and consulting projects in five years.
OUR EXPERTS 

Meet Veristat’s clinical development experts

Our experts identify scientific and operational risks early and build strategies to manage them before timelines are affected.

View our leadership team →

ourexperts
CLIENT TESTIMONIALS

What clients say about working with us

“Veristat provided strong data, very high-quality stats work, as well as fair, balanced, and compelling medical writing telling the story behind the data. Your team contributed essentially to all areas. Our sincere thanks for the partnership that made the preparation of our now-approved NDA possible.”

SVP Regulatory Affairs

Medium Biopharmaceutical Company

INSIGHT & EXPERTISE

Expore our Resources